Image Courtesy : www.moneycontrol.com

Along with other countries, India is also in the race to make Coronavirus vaccine. According to the authorities, total 30 groups are working on this vaccine in which six shows much progress.

CCMB (Centre for Cellular and Molecular Biology) has successfully isolated the virus from several isolates. This would enable the researchers at the CCMB to culture the virus and work towards vaccine development. The cultures would then be used in drug screening and can be tested against potential drugs in test tubes.

Serum Institute - Pune based SII is one of the leading contenders in the research for a vaccine. The largest vaccine producer is working with the University of Oxford to find a safe and affordable COVID vaccine. The Oxford is conducting clinical trials and SII is speeding up work to ensure that doses of the same are available as early as October.

Meanwhile, leading pharma company NOVAVAX is going to buy a SII's manufacturing plant and planning to produce a billion doses of coronavirus vaccine by next year. The company would buy Czech Republic-based Praha Vaccines, a unit of India's Cyrus Poonawalla Group that owns Serum Institute for $ 167 million.

Reference: Business Today.